Reveals significant non-carcinogenic risks from PCB exposure in waste sites, indicating urgent regulatory changes.
This study investigated the cumulative human health risks from low-level polychlorinated biphenyl (PCB) exposure in diverse waste environments, challenging conventional regulatory thresholds based on high-dose toxicity. Concentrations of 14 PCB congeners were quantified across five waste types using Gas Chromatography coupled with Mass Spectrometry (GC-MS), and cumulative non-carcinogenic and carcinogenic risks were assessed via hazard quotient (HQ) and cancer risk (CR) models. This study integrates congener-pattern analysis with physicochemical covariates to isolate source-specific risk drivers, advancing beyond traditional total-PCB approaches. Results revealed significant spatial variation, with PCB-20 and PCB-137 as dominant contributors. Total HQ values ranged from 5.36 to 6.70, all exceeding the safe threshold of 1, indicating substantial non-carcinogenic risks. CR values (3.7–4.7 × 10 −5 ) fell within acceptable limits but signify notable lifetime risks. A strong positive correlation was found between electrical conductivity (EC) and PCB mobility, while alkaline pH promoted persistence. The findings demonstrate that chronic, low-level exposure in waste sites poses significant cumulative health threats, primarily through non-cancer effects. This underscores the inadequacy of current standards and necessitates a shift toward cumulative, congener-specific risk assessment frameworks for effective regulation and remediation in developing regions.
No takes yet. Share an insight, caveat, or question.
Oguntimehin et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: